Dec 09, 2010
The Society is pleased to announce the results of the 2011 ASCO Election: Sandra M. Swain, MD, will take office as President-Elect during ASCO’s 47 Annual Meeting in June 2011 and will serve for a one-year term as President beginning in June 2012. In addition, four new members of the Board of Directors and two new members of the Society’s Nominating Committee have been elected.
“These highly qualified individuals bring a wealth of experience to ASCO leadership,” said ASCO CEO Allen S. Lichter, MD. “It will be my privilege to work with the newly elected President-Elect, Dr. Sandra Swain, and the newly elected Board Members. ASCO is fortunate to have such a dedicated oncologist and ASCO member to help lead the Society’s efforts to improve all aspects of cancer care.”
“I am honored to be elected to serve as President of ASCO and for the opportunity to serve the organization in this new capacity,” said Dr. Swain. “ASCO’s dedicated members are the reason why ASCO is such an exceptional organization, and I look forward to working with my colleagues on the Board of Directors to continue to pursue the Society’s mission to improve all the lives of people affected by cancer.”
The President-Elect and members of the Board of Directors and Nominating Committee are dedicated to advancing the ASCO mission and will promote policies to:
- increase financial support for oncology research;
- ensure timely dissemination of new research;
- support programs for survivors;
- improve access to clinical trials;
- develop strategies for alleviating the future shortage in the oncology workforce;
- and advance basic, translational, and clinical research through collaborations with public and private entities.
The newly elected officials will take office at the 2011 Annual Business Meeting.
2011 ASCO Election Results
Sandra M. Swain, MD
(Presidential term 2012-2013)
Dr. Swain is the Medical Director of Washington Hospital Center’s Washington Cancer Institute, Professor in the Department of Medicine at Georgetown University, and Adjunct Professor of Medicine in the F. Edward Hebert School of Medicine at the Uniformed Services University of the Health Sciences. She has worked at the Washington Hospital Center since 2007 and the Uniformed Services University of the Health Sciences since 2002.
Since joining ASCO in 1986, Dr. Swain has demonstrated a comprehensive record of service to the Society. She served on the Board of Directors (2008-2011); Finance Committee (2008-2011); Strategic Planning Committee (2008-2011); the Advisory Group for the Susan G. Komen for the Cure®/The ASCO Cancer Foundation® Collaborative Commitment (2008-2009); The ASCO Cancer Foundation® (now the Conquer Cancer Foundation) Board (2007-2010); Timely Oncology Perspectives (2007-2010); Breast Cancer Symposium Program Committee (2006-2009); Cancer Education Committee (2006-2007); Best of ASCO® Planning Committee (2005-2007); Nominating Committee (2003-2004); Sponsorship Committee (2000-2002); and the Audit and Finance Committee (1998-2001). She also serves as Board Liaison for the Ethics Committee (2008-2011) and the National Accreditation Program for Breast Centers (2006-2012).
During her term, Dr. Swain will reach out to the National Cancer Institute (NCI) with a goal of improving translational medicine by increasing the connection between clinical and basic scientists. She will also address the potential shortage of primary care and medical oncology physicians by promoting the training of extended practice nurses, physician assistants, and other health care providers. In addition, Dr. Swain will ensure that ASCO’s Quality Oncology Practice Initiative (QOPI®) moves forward and develops metrics for successful outcomes. Finally, she will champion for ASCO to work in tandem with NCI and other leaders to implement a successful national clinical research plan in oncology.
Board of Directors
Gary I. Cohen, MD
Dr. Cohen is the Medical Director of the Berman Cancer Institute at Greater Baltimore Medical Center, the Administrative Director of the Sidney Kimmel Foundation for Cancer Research, and an Assistant Professor of Oncology at Johns Hopkins University.
During his term, Dr. Cohen will work with the Board of Directors to involve community physicians in clinical trials through education, encouragement, and funding. He will also champion for community oncologists to “step up to the plate” in encouraging patients to enroll in clinical trials, and he will work to promote a rational approach to cancer care in the United States that is driven by appropriate clinical care guidelines.
Carolyn D. Runowicz, MD
Dr. Runowicz is Director of the Carole and Ray Neag Comprehensive Cancer Center and Northeast Utilities Chair in Experimental Oncology at the University of Connecticut Health Center. She is also a professor and attending gynecologic oncologist in the Department of Obstetrics and Gynecology at that institution. Dr. Runowicz has been a part of the University of Connecticut Health Center since 2003.
During her term, Dr. Runowicz will work with the Board of Directors to address workforce issues; develop the Society’s strategic plan; address access to quality care in oncology, especially in view of health care reform; and focus on physician reimbursement.
Eric P. Winer, MD
Dr. Winer is Director of the Breast Oncology Center, Chief of the Division of Women’s Cancers, and Thompson Senior Investigator in Breast Cancer Research at Dana-Farber Cancer Institute. He is also a Professor of Medicine at Harvard Medical School.
During his term, Dr. Winer will work with the Board of Directors to eliminate wasted expenses in health care costs, push the clinical research agenda by lobbying for additional funding, and minimize the delays and administrative obstacles that have crept into health care systems.
Daniel F. Hayes, MD
Dr. Hayes is a Professor of Internal Medicine, the Stuart B. Padnos Professor in Breast Cancer, and the Clinical Director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center.
During his term, Dr. Hayes will work with the Board of Directors in support of clinical care quality initiatives, including QOPI. He envisions ASCO partnering with complementary societies to bring standardized, high-quality care to patients, regardless of where they live or are treated. He will also work to enhance, streamline, and facilitate properly conducted clinical and translational research by championing for ASCO to partner with constituencies that have considerable political weight and leadership. He will advocate for community oncologists to ensure that they can continue to deliver high-quality cancer care. Dr. Hayes will support ASCO’s efforts in international clinical and research training.
Kathy D. Miller, MD
(2011-2014; Chair, 2013-2014)
Dr. Miller is the Sheila D. Ward Scholar and Associate Professor of Medicine at Indiana University School of Medicine, as well as an attending physician at Indiana University Hospital and consulting physician at Wishard Memorial Hospital and Richard L. Roudebush VA Medical Center. Her professional interests include new cancer treatments and clinical trials of biologically based therapies.
Dr. Miller will seek to increase membership participation in Society elections by working to provide members with 1) a clear choice of candidates, 2) an opportunity to directly pose questions to candidates, and 3) the opportunity to share their opinions about important matters facing the Society.
Harold J. Burstein, MD, PhD
Dr. Burstein is an Associate Professor of Medicine at Harvard Medical School and a medical oncologist at Dana-Farber Cancer Institute and Brigham & Women’s Hospital. His professional interests include breast oncology and clinical treatment trials for early- and late-stage breast cancer.
Dr. Burstein will work to increase membership participation in the Society’s elections by helping to put forward slates of candidates who have broad and resonant appeal to ASCO membership. He will also promote the idea of “paying” members to vote by offering vouchers that would be good toward annual membership dues, meeting registration, educational materials, or other ASCO products. He also supports scheduling elections at the Annual Meeting since thousands of members are on hand and available to cast ballots.